Are Orphan Incentives Necessary For Development? Sponsors Aren't So Sure

Drug sponsors tell US GAO that orphan incentives don't draw them to the space, and several stakeholders say high prices and scientific discovery are the reason for the sector's growth.

Dollar sign made with drug pills

Drug sponsors gave a less than overwhelming endorsement of orphan incentives to the US Government Accountability Office, a potentially concerning revelation for advocates and other stakeholders.

The sample size was small (only four manufacturers were interviewed for the GAO study) but two of the sponsors...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Rare Diseases

More from Pink Sheet